177 related articles for article (PubMed ID: 21412503)
1. Upregulated CD133 expression in tumorigenesis of colon cancer cells.
Yang ZL; Zheng Q; Yan J; Pan Y; Wang ZG
World J Gastroenterol; 2011 Feb; 17(7):932-7. PubMed ID: 21412503
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
3. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.
Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P
Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631
[TBL] [Abstract][Full Text] [Related]
4. Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo.
Peickert S; Waurig J; Dittfeld C; Dietrich A; Garbe Y; Kabus L; Baumann M; Grade M; Ried T; Kunz-Schughart LA
Lab Invest; 2012 Nov; 92(11):1607-22. PubMed ID: 22964855
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line.
Feng JM; Miao ZH; Jiang Y; Chen Y; Li JX; Tong LJ; Zhang J; Huang YR; Ding J
Cancer Biol Ther; 2012 Dec; 13(14):1396-406. PubMed ID: 22954703
[TBL] [Abstract][Full Text] [Related]
6. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
Pitule P; Cedikova M; Daum O; Vojtisek J; Vycital O; Hosek P; Treska V; Hes O; Kralickova M; Liska V
Biomed Res Int; 2014; 2014():432139. PubMed ID: 24864242
[TBL] [Abstract][Full Text] [Related]
8. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer.
Elsaba TM; Martinez-Pomares L; Robins AR; Crook S; Seth R; Jackson D; McCart A; Silver AR; Tomlinson IP; Ilyas M
PLoS One; 2010 May; 5(5):e10714. PubMed ID: 20502714
[TBL] [Abstract][Full Text] [Related]
9. Cytometric profiling of CD133+ cells in human colon
carcinoma cell lines identifies a common core phenotype
and cell type-specific mosaics.
Gemei M; Di Noto R; Mirabelli P; Del Vecchio L
Int J Biol Markers; 2013 Sep; 28(3):267-73. PubMed ID: 23709346
[TBL] [Abstract][Full Text] [Related]
10. [CD133(+) Colo205 colorectal cancer cells express high levels of ALDH1 in serum-free culture].
Li L; Zhang S; Liang F; Lin Y; Li R; Chen C; Xiao B
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):889-93. PubMed ID: 23803205
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
[TBL] [Abstract][Full Text] [Related]
12. CD133 and CD133-regulated nucleophosmin linked to 5-fluorouracil susceptibility in human colon cancer cell line SW620.
Kim KH; Yoo BC; Kim WK; Hong JP; Kim K; Song EY; Lee JY; Cho JY; Ku JL
Electrophoresis; 2014 Feb; 35(4):522-32. PubMed ID: 24339132
[TBL] [Abstract][Full Text] [Related]
13. CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo.
Gemei M; Mirabelli P; Di Noto R; Corbo C; Iaccarino A; Zamboli A; Troncone G; Galizia G; Lieto E; Del Vecchio L; Salvatore F
Cancer; 2013 Feb; 119(4):729-38. PubMed ID: 23027178
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of CD133(+) human colon cancer SW620 cells.
Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N
Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Prominin 1/CD133 expression in colorectal cancer by NSAIDs following short-term preoperative treatment.
Lönnroth C; Andersson M; Nordgren S; Lundholm K
Int J Oncol; 2012 Jul; 41(1):15-23. PubMed ID: 22552364
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analyses of CD133 expression facilitate researches on tumor stem cells.
Liao Y; Hu X; Huang X; He C
Biol Pharm Bull; 2010; 33(5):738-42. PubMed ID: 20460748
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin extra domain A (EDA) sustains CD133(+)/CD44(+) subpopulation of colorectal cancer cells.
Ou J; Deng J; Wei X; Xie G; Zhou R; Yu L; Liang H
Stem Cell Res; 2013 Sep; 11(2):820-33. PubMed ID: 23811539
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer.
Kemper K; Versloot M; Cameron K; Colak S; de Sousa e Melo F; de Jong JH; Bleackley J; Vermeulen L; Versteeg R; Koster J; Medema JP
Clin Cancer Res; 2012 Jun; 18(11):3132-41. PubMed ID: 22496204
[TBL] [Abstract][Full Text] [Related]
19. Nanog: a potential biomarker for liver metastasis of colorectal cancer.
Xu F; Dai C; Zhang R; Zhao Y; Peng S; Jia C
Dig Dis Sci; 2012 Sep; 57(9):2340-6. PubMed ID: 22562535
[TBL] [Abstract][Full Text] [Related]
20. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
